As of 2025-11-04, the EV/EBITDA ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is -2.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASP.TO's latest enterprise value is 63.17 mil CAD. ASP.TO's TTM EBITDA according to its financial statements is -25.78 mil CAD. Dividing these 2 quantities gives us the above ASP.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 4.5x | 4.3x |
| Forward P/E multiples | 3.4x - 5.2x | 4.3x |
| Fair Price | (23.96) - (28.92) | (27.99) |
| Upside | -6754.5% - -8134.3% | -7874.0% |
| Date | EV/EBITDA |